The Predictors for Severe SARS-CoV-2 Omicron (B.1.1.529) and Pre-Omicron Variants Infection Among Kidney Transplant Recipients.
作者信息
Banjongjit Athiphat, Lertussavavivat Tanat, Paitoonpong Leilani, Putcharoen Opass, Vanichanan Jakapat, Wattanatorn Salin, Tungsanga Kriang, Eiam-Ong Somchai, Avihingsanon Yingyos, Tungsanga Somkanya, Townamchai Natavudh
机构信息
Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
出版信息
Transplantation. 2022 Dec 1;106(12):e520-e521. doi: 10.1097/TP.0000000000004361. Epub 2022 Oct 3.
Abstract
摘要
相似文献
1
The Predictors for Severe SARS-CoV-2 Omicron (B.1.1.529) and Pre-Omicron Variants Infection Among Kidney Transplant Recipients.
Transplantation. 2022 Dec 1;106(12):e520-e521. doi: 10.1097/TP.0000000000004361. Epub 2022 Oct 3.
2
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.
Am J Transplant. 2022 Jul;22(7):1873-1883. doi: 10.1111/ajt.17054. Epub 2022 Apr 18.
3
Mortality Due to COVID-19 in Renal Transplant Recipients, Related to Variants of SARS-CoV-2 and Vaccination in Mexico.
Transplant Proc. 2022 Jul-Aug;54(6):1434-1438. doi: 10.1016/j.transproceed.2022.05.010. Epub 2022 Jun 1.
4
COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes.
Transplantation. 2022 Sep 1;106(9):1860-1866. doi: 10.1097/TP.0000000000004203. Epub 2022 Aug 19.
5
Preexisting renal graft dysfunction as a major risk factor for SARS-CoV-2 Omicron variant pneumonia: A postinfection cross-sectional study of 312 immunosuppressed renal transplant recipients.
Int J Infect Dis. 2024 Apr;141:106962. doi: 10.1016/j.ijid.2024.02.005. Epub 2024 Feb 13.
6
SARS-CoV-2 Omicron infection in a cohort of hospitalized kidney transplant recipients: Risk factors of severity.
Clin Nephrol. 2024 May;101(5):238-249. doi: 10.5414/CN111303.
7
Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.
Kidney Int. 2022 Jun;101(6):1282-1286. doi: 10.1016/j.kint.2022.04.009. Epub 2022 Apr 13.
8
Trends in COVID-19 Outcomes in Kidney Transplant Recipients During the Period of Omicron Variant Predominance.
Transplantation. 2022 Jun 1;106(6):e304-e305. doi: 10.1097/TP.0000000000004126. Epub 2022 Apr 6.
9
Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients.
Kidney Int. 2022 Aug;102(2):440-442. doi: 10.1016/j.kint.2022.05.007. Epub 2022 May 23.
10
Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Transpl Infect Dis. 2023 Jun;25(3):e14024. doi: 10.1111/tid.14024. Epub 2023 Feb 7.
引用本文的文献
1
Incidence, severity, risk factors and outcomes of SARS-CoV-2 reinfections during the Omicron period: a systematic review and meta-analysis.
J Glob Health. 2025 Feb 7;15:04032. doi: 10.7189/jogh.15.04032.
2
Immunogenicity and Predictive Factors Associated with Poor Response after Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Lung Transplant Patients.
Vaccines (Basel). 2024 Jul 22;12(7):822. doi: 10.3390/vaccines12070822.
3
COVID-19 Outcomes in Kidney Transplant Recipients in a German Transplant Center.
J Clin Med. 2023 Sep 21;12(18):6103. doi: 10.3390/jcm12186103.
4
Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients.
Transplant Direct. 2023 Sep 20;9(10):e1536. doi: 10.1097/TXD.0000000000001536. eCollection 2023 Oct.
Zotero 插件